chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given Varivax subcutaneous in left arm tricep area, MMR II right arm tricep area, and Hepatitis B Hepislav-B IM in left deltoid around 11:45 AM in a clinic setting by me. After giving all vaccines patient became lethargic, diaphoretic, pallor, and had a thready pulse of 20-30s after 1 minute. Patient legs were elevated and patient was reclined on exam table. EMS was called and patient remained lethargic, pale, with pulse in 20-30s, with pulse oximeter of 85% on room air (we do not have oxygen in this clinic). Gave patient an ammonia inhalant and patient began to be more conversant after 5 minutes. Pulse now in  40-50s. Paramedics arrived after 5 minutes, patient now alert and oriented, EKG performed and patient was in sinus rhythm. Patient was taken to Hospital for further work up but was discharged around 2:00 PM. Patient came back by clinic to thank clinic staff. Patient did inform staff after the situation that he had not eaten, had worked out and taken pre-workout before vaccination appointment.
2 days after started falling to the ground again; more sweating; fatigue; Muscle collapsing down; muscle tightening; weakening of muscles/paralyzing effects of their muscles/muscle collapsing; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Oct2021 (Lot number: 30135BA) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Autoimmune disorder" (unspecified if ongoing), note: resulted from an exposure to chemicals. Concomitant medication included: THYROXINE taken for autoimmune disorder, start date: 19May2018. Vaccination history included: Bnt162b2 (Dose:01, Lot number: EM6203, Anatomical location: right arm.), administration date: 19Mar2021, for covid-19 immunisation, reaction: "Muscle weakness", "aching arm", "paralyzing effects of their muscles"; Bnt162b2 (Dose:02, Lot number: ER8727, Anatomical location: right arm.), administration date: 09Apr2021, for COVID-19 Immunization, reaction: "Muscle weakness", "paralyzing effects of their muscles", "aching arm". The following information was reported: PARALYSIS (medically significant) with onset Oct2021, outcome "unknown", described as "weakening of muscles/paralyzing effects of their muscles/muscle collapsing"; FALL (non-serious) with onset 23Oct2021, outcome "unknown", described as "2 days after started falling to the ground again"; HYPERHIDROSIS (non-serious) with onset Oct2021, outcome "unknown", described as "more sweating"; FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "fatigue"; MUSCLE ATROPHY (non-serious) with onset Oct2021, outcome "unknown", described as "Muscle collapsing down"; MUSCLE TIGHTNESS (non-serious) with onset Oct2021, outcome "unknown", described as "muscle tightening". Therapeutic measures were taken as a result of paralysis, muscle tightness. Clinical course: the patient had the vaccination in the end of Oct2021, 2 days after started falling to the ground again then she started to experience more sweating, fatigue and collapsing down again. At the end of Oct2021, 2 days after, it looks like she started feeling sweating and muscle tightening. The patient clarified that she does science research.
Breaking in hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Breaking in hives) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO) for Anticoagulant therapy.    On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced URTICARIA (Breaking in hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Breaking in hives) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included: Birth control pills.   This case was linked to MOD-2021-162309 (Patient Link).
pt 's mom recv vax;pt devel chicken pox w/ T & lesions on scalp, face, arm and back;another sibling devel chicken pox;mom felt that there was transmission of virus from her to children;however cultures of children were obtained;
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: PT STATED AND ALSO OBSERVED REDNESS AND  SWELLING AROUND THE INJECTION SITE WAS SEEN BY MD AND GIVEN ANTIBIOTICS TO TREAT CELLULITIS
While taking a Physical Fitness Test I had a syncopal episode. A ECG taken that day showed prolonged QT interval and right bundle branch block. I have been evaluated and a ICD was implanted in December 2006. I have symptoms of Long QT Syndrome and Brugada Syndrome but genetic testing is negative for both. There is no family history of syncope, Long QT Syndrome, Brugada Syndrome or sudden unexplained death.
Pooping 5 times per day (not diarrhea), fatigue, weakness, chills, intense muscle aches and intense headache.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates in 2014, reported as from 10-JUN-2014 to 18-JUL-2014, an unspecified number of patients were vaccinated with doses of VAQTA (dose number, dose, route and lot number was not reported), which were improperly stored. No adverse events were reported. Concomitant medications were not specified. Follow up was received from a medical assistant and refers to a 6 years old patient of unknown gender. On 09-JUL-2014 the patient was vaccinated with a dose of VAQTA lot # J005010 and expiry date 23-OCT-2014 the patient was vaccinated with a dose of VAQTA lot # J005010 and expiry date 23-OCT-2015 (dose, route not reported) that on 10-JUL-2014 had been exposed to 51 degrees Fahrenheit for 51 minutes. This is one of several reports received from the same reporter. Additional information is not expected as no follow up was obtained.
BORDERLINE CASE OF LEUKEMIA; LOCAL INJECTION RESPONSE TO THE VACCINE; This spontaneous report received from a patient via a company representative concerned a 61 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A,expiry: unknown) dose was not reported, 1 in total, administered on 03-MAY-2021 to left arm for covid-19 prophylaxis. Age at time of vaccination 61 years old. No concomitant medications were reported.  On 03-MAY-2021, right after vaccination, the patient experienced local injection response to the vaccine, which was expected. Several months following that, on an unspecified date the patient developed borderline case of leukemia. The patient stated that her white blood cell and absolute counts started going up and she believes that this is partially due to the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from borderline case of leukemia, and the outcome of local injection response to the vaccine was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20230235262- borderline case of leukemia- The event has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable
Pt has history of anaphylaxis, carries Epi pen. Complained of feeling odd, similar to how she felt before previous anaphylactic reaction.  Place pt on cot, code green called.  Paramedics assessed BP 162/102, HR 106, GLUCOSE 114.  Attempted to sit pt up had near syncopal episode, rapid eye fluttering BP 172/126.  PT was transported to hospital.
Athough I also had headaches chills they went away after a couple days but pain in arm still persists  as to where I have a hard time functioning cant carry heavy objects ibuprofen seems to take the edge off but concerned about long term effects of eating ibuprofen called clinic for follow up got put on phone with pharmacist who seems clueless any assistance on what to do to fix this would be highly appreciated . today makes 11 days did not check temperature when had headache
A report has been received from a Physician concerning an 18 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 14-Nov-2013. It was reported that consumer was inadvertently given FLUMIST quadrivalent to a pregnant woman which started on 14-Nov-2013. The pregnancy outcome was unknown, last menstruation was in Apr-2013, and the expected delivery date was Jan-2014. The outcome of the event of inadvertently gave FLUMIST quadrivalent to a pregnant woman is unknown. The patient was pregnant and due date was found to be Jan-2014 and pregnancy result was unknown. The report was considered to be non-serious by the reporter. Follow-up of insignificant information received by AstraZeneca/MedImmune 26-Nov-2013 from physician: patient initials changed, last menstruation date added and narrative updated.
nausea; felt bad; Fever; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), PYREXIA (Fever), VACCINATION SITE PAIN (Soreness) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FEELING ABNORMAL (felt bad), PYREXIA (Fever) and VACCINATION SITE PAIN (Soreness). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, FEELING ABNORMAL (felt bad), PYREXIA (Fever) and NAUSEA (nausea) had resolved and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-100950 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up information was received on 02-MAY-2021: Added event
Pt reported that she did not feel well for a week after receiving the immunizations. On 9/22, she developed 1 shingle on her right forearm; by 9/23, she had developed a second shingle.  She complains of pain radiating from her right forearm to shoulder. She has also developed pain in right hip, back, and buttocks.
Information has been received from a licensed visiting nurse concerning an 11 year old female who in 1997 was vaccinated with a dose of varicella vaccine. On 10/16/2001, the pt was diagnosed with shingles. It was also reported that the pt had a fever and malaise a few days before onset of shingles. There was no medical history or other additional info available. The pt sought unspecified medical attention. On 10/19/2001, it was reported that the pt was recovering. Additional info has been requested.
received 3rd dose of COVID-19 Vaccine; didn't feel well; This is a spontaneous report from a contactable other HCP (nurse). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date was not reported), via an unspecified route of administration on an unspecified date as dose 3, (booster) single for COVID-19 immunization (at the age of 55-year-old). The patient previously took dose 1 and dose 2 of BNT162B2 via an unspecified route of administration on an unspecified date as single for COVID-19 immunization. Medical history included attention deficit hyperactivity disorder from an unknown date and unknown if ongoing and allergies from Hydrocodone, Norco, Hydrocodon-Acetaminophen. Concomitant medication(s) included ibuprofen (ADVIL [IBUPROFEN]); calcium carbonate; melatonin; paracetamol (TYLENOL); vitamin D3. The patient experienced received 3rd dose of covid-19 vaccine and didn't feel well for 8 days on an unspecified date. Patient stated Doctor was not aware. The outcome of the events was unknown.  This lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
pt recv 2 doses of vax 17FEB97 & 17MAR97 & 12MAY97 pt lab eval was IgM negative which corresponds to a lack of seroconversion;
when she got home after getting her vaccine she lost her voice. She compared it to having laryngitis
Within hours of administration to left deltoid, developed blurred vision right eye, fatigue with generalized weakness, and massive swelling and discomfort at injection site. Pt declined eval initially. Presented 7 days later for eval.
Sore injection site & arm muscle, pain in knee joints, fever of 100.9, chills, lethargic, loss of appetite. lasted 2.5 days.
woke up with pain that shot up to the neck. the area was swollen and hot. which prompt patient to go to ER. The physician subsequently diagnosed patient with superficial arm blood clot. patient has a follow up visit to investigate if a presence of blood clot which is causing  sob is related to the immunization
1/2 hour after - felt pent up like I had to sigh to return to normal 24 hours later - heavy fatigue,  low grade fever 99.3, achiness since then fatigue, sometimes very bad which makes me miss planned activities, sometimes not as bad and I can flounder through
After individual received dose of Janssen vaccine, the vaccinator realized he had received a first dose of Moderna vaccine on 3/11/21, but had not received a second dose. No adverse reactions noted. Individual counseled and advised not to return for second dose of Moderna vaccine.
Patient experienced redness, soreness, hardness, it was raised and approximately 4 inches in diameter. Warm to touch. Experienced some fatigue.
patient stated she had redness and swelling with lots of "heat" in her arm. Pain when she lowered her arm below shoulder height.
Pt received Pfizer vaccines on 06/14/21 and 07/05/21. Pt presented to the ED on 11/29/21 with complaints of fatigue, SOB, and weakness. Pt was found to be COVID positive requiring supplemental oxygen.
Had the shot and got shingles/suspected vaccination failure; Shingles; Pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shot and got shingles/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and pain (Verbatim: Pain). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 12-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received Shingles vaccine and still experienced shingles. The patient had pain. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
On 4/5/2021 at 8:00 PM, developed strong headache.  Went to lay down, developed racing heart rate, heaviness in chest, itchy and swollen hands. With restless night.  The next morning on 4/6/2021, had an appointment with my dermatologist, described symptoms, she told me to call my primary care doctor.  Spoke with Dr. She told me to go to the Emergency Room to report my symptoms based on the J&J vaccine.  Arrived at ER at 2:00 PM on 4/6/2021.  Have received a total billing amount of $ 2,123.39 as a result of my reaction to the J&J Vaccine.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium
Herpes zoster without complication.  Symptoms appears ~8-9 days after vaccination. Rash and pain located in back and upper on  right side only
Approx 14 minutes after receiving the vaccine, client felt like his heart was racing and his blood pressure elevated, and dizzy. vital signs monitored, his BP was 150/108. He was clammy and shaky He was taken behind the white curtain and took his mask off, which he said helped tremendously. He was monitored. BP down to 140/100. He recently started BP medication. Told to discuss this episode with his PCP.
Nagging pain in L/arm for over 2 mos. Pain radiates up & down arm into shoulder & neck area. Numbness in fingertips L/hand, limited mobility of L/arm due to pain. Saw Dr 12/7; tx'd w/Naproxen Sodium for 2 wks. Still exists, no dx.
itchy throat; facial swelling; my mouth felt flushed and strange/face became flushed; pale; This is a spontaneous report from a contactable consumer (patient) reported that: A 36-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in left arm, on 02Mar2021 at 09: 15 AM, as dose 1 single for COVID-19 immunization at hospital. The patient medical history included hip surgery. Concomitant medication included Cerebrex, acetaminophen, vit d, and b complex. The patient did not have any known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 02Mar2021 09:30 itchy throat, facial swelling, my mouth felt flushed and strange, face became flushed and pale. She explained within few minutes post vaccination she experienced an itchy throat, and 10 minutes later she had facial swelling. She added 30 minutes post-vaccination, her symptoms were resolved, and she was able to go home. She asked if her symptoms were reported as a side effect to the vaccine. She experienced throat itchiness 1 minute after administration then followed by mouth flushing. 15 minutes later, she experienced face flush, but it went away after. She wanted to know if these reactions are common and if other people experience it and how they handled it. Second dose was due on 23Mar2021. Within a couple of minutes of getting my first vaccine, my throat became itchy, and my mouth felt flushed and strange. Ten minutes later my face became flushed. 15 minutes later I became very pale and was instructed to sit and was given water, crackers, and chocolate. After 30 minutes, the symptoms went away, and I went home. The patient did not receive any treatment for the events. Outcome of the event was recovered on unspecified date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I had the J&J shot in April and just got the Pfizer as a booster. I also had the flu shot done at the same time in my other arm. Two days later, I?m feeling chest pain when I breathe out and anytime I move part of my upper body.  It also hurts when I press on my chest.
Arm was red hard and swollen. The rash spread to the whole side of my left side
Shortly after this vaccine, patient began covering her ears and screaming in pain when she encountered certain noises, lights, textures, clothing. These were normal day to day activities, but to her they were excruciating. Instead of getting better, she got worse and was diagnosed with Autism Spectrum disorder on January 7, 2019.
Presents for cough, SOB, weakness x1wk. Saw PCP PTA & dx w/pneumonia but not tested for COVID. Admit for COVID pneumonia. Tx: dexamethasone, zinc, vit c. DC home
pt recv vax 15OCT97 & 3 days p/vax pt exp h/a, nausea & aches;h/a described as bad h/a that are progressively worse;
After receiving the 2nd dose of the vaccination, I experienced dizziness, a sore right arm, swelling and brain fog also a cough was present.
swollen arm as a side effect/Right arm swelling; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number (Lot number reported either EL8982, LL8982, or 6L8982), expiration date unknown), via an unspecified route of administration in the right arm on 15Jan2021 at 14:30 to at a single dose for COVID-19 immunisation.  Medical history and family medical history were reported none.  The patient had no prior vaccinations within four weeks.  There were no concomitant medications.  On 15Jan2021, the patient experienced swollen arm as a side effect/ right arm swelling. It was reported that right arm swelling began in the evening. It was also reported that arm was still swollen, but has gotten a little better.  The patient asked how long that will last, how to treat the swelling, and if she can go for the second inoculation. The outcome of the event was recovering.  Information about lot/batch number has been requested.
I felt fatigue and I had pain in my left arm. These lasted for about 2 days and then they were gone.
Child was seen in clinic for immunizations. After being educated, mother of child agreed to TdaP, MENACTRA, and HPV vaccines. At the beginning of the visit, the child was very energetic, talkative, and active. About two minutes after receiving the vaccines, the child became lethargic, dazed, unsteady gait, in a stupor, and disoriented. The child never lost consciousness, but displayed a noticeable difference in personality after the vaccines were administered. I observed the child in clinic for approximately 45 minutes, and he never returned to his original state. He was walking and talking clearly before he left, but was quiet and reported being really tired.
09/10/22 presents to EC ED for "loss of vision". PMHx of "HTN"
Had vaccine on 3/19/03. Developed a severe rash on 3/27/03. worsened enough to see doctor on 4/7/03. Continued to worsen. Saw pediatric dermatologist on 4/17/03; said it looks like its clearing up. Could have been a reaction when given.
PATIENT HAD SWELLING OF ARM WITH GOLF BALL SIZE REDNESS WITH HARD LUMP UNDERNEATH 1CM LESS IN DIAMETER THAN THE REDNESS AREA. COLD COMPRESSES APPLIED AND REDNESS MARKED TO MONITOR IF WORSENING WILL CONTINUE TO MONITOR.